PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
32011533-1	2020	OBJECTIVE: The aim of this study was to investigate the effects of eupatilin on protein kinase D1 (PKD1) and nuclear factor kappa B (NF-kappaB) signaling pathways in cerulein-induced in vitro pancreatitis.	eupatilin	67-76	protein kinase D1	Mus musculus	80-97	
32011533-1	2020	OBJECTIVE: The aim of this study was to investigate the effects of eupatilin on protein kinase D1 (PKD1) and nuclear factor kappa B (NF-kappaB) signaling pathways in cerulein-induced in vitro pancreatitis.	eupatilin	67-76	protein kinase D1	Mus musculus	99-103	
32011533-9	2020	Eupatilin inhibited cerulein-induced activation of PKD1/NF-kappaB and the nuclear translocation of NF-kappaB.	eupatilin	0-9	protein kinase D1	Mus musculus	51-55	
32011533-10	2020	CONCLUSIONS: Our data demonstrated that eupatilin is a potential therapeutic candidate for the treatment of pancreatitis through its ability to reduce cellular necrosis and inflammatory responses by inhibition of the PKD1/NF-kappaB signaling pathway.	eupatilin	40-49	protein kinase D1	Mus musculus	217-221